David Tarazona

432 total citations
23 papers, 196 citations indexed

About

David Tarazona is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, David Tarazona has authored 23 papers receiving a total of 196 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in David Tarazona's work include Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (6 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). David Tarazona is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (6 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). David Tarazona collaborates with scholars based in Peru, Brazil and Spain. David Tarazona's co-authors include Heinner Guio, Kelly S. Levano, César Sánchez, Marco Galarza, Víctor Borda, Eduardo Tarazona‐Santos, Omar Cáceres, Carlos Padilla, Timothy D. O’Connor and Daniel Harris and has published in prestigious journals such as Proceedings of the National Academy of Sciences, International Journal of Molecular Sciences and Journal of Medical Virology.

In The Last Decade

David Tarazona

21 papers receiving 194 citations

Peers

David Tarazona
Abrar Ahmad Pakistan
Jeffrey K. J. Cheng United Kingdom
Meagan Rubel United States
Ethan Chen United States
Maurice Steenhuis Netherlands
David Tarazona
Citations per year, relative to David Tarazona David Tarazona (= 1×) peers Yuqian Yan

Countries citing papers authored by David Tarazona

Since Specialization
Citations

This map shows the geographic impact of David Tarazona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tarazona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tarazona more than expected).

Fields of papers citing papers by David Tarazona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Tarazona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tarazona. The network helps show where David Tarazona may publish in the future.

Co-authorship network of co-authors of David Tarazona

This figure shows the co-authorship network connecting the top 25 collaborators of David Tarazona. A scholar is included among the top collaborators of David Tarazona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Tarazona. David Tarazona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levano, Kelly S., David Tarazona, César Sánchez, et al.. (2024). Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations. Pharmacology Research & Perspectives. 12(3). e1179–e1179.
2.
Levano, Kelly S., David Tarazona, César Sánchez, et al.. (2022). GSTT1/GSTM1 Genotype and Anti-Tuberculosis Drug-Induced Hepatotoxicity in Peruvian Patients. International Journal of Molecular Sciences. 23(19). 11028–11028. 5 indexed citations
3.
Levano, Kelly S., David Tarazona, César Sánchez, et al.. (2022). NAT2 and CYP2E1 polymorphisms and antituberculosis drug‐induced hepatotoxicity in Peruvian patients. Molecular Genetics & Genomic Medicine. 10(8). e1987–e1987. 10 indexed citations
4.
Tarazona, David, et al.. (2022). A Closer Look at ACE2 Signaling Pathway and Processing during COVID-19 Infection: Identifying Possible Targets. Vaccines. 11(1). 13–13. 3 indexed citations
5.
Tarazona, David, et al.. (2021). A Multiplex and Colorimetric Reverse Transcription Loop-Mediated Isothermal Amplification Assay for Sensitive and Rapid Detection of Novel SARS-CoV-2. Frontiers in Cellular and Infection Microbiology. 11. 653616–653616. 24 indexed citations
6.
Tarazona, David, et al.. (2021). Phylogenomics reveals multiple introductions and early spread of SARS‐CoV‐2 into Peru. Journal of Medical Virology. 93(10). 5961–5968. 12 indexed citations
7.
Levano, Kelly S., David Tarazona, César Sánchez, et al.. (2021). Allelic and genotypic frequencies of NAT2 , CYP2E1 , and AADAC genes in a cohort of Peruvian tuberculosis patients. Molecular Genetics & Genomic Medicine. 9(10). e1764–e1764. 10 indexed citations
8.
Levano, Kelly S., et al.. (2021). CXCR4 Knockdown Via CRISPR/CAS9 in a Tumor-Associated Macrophage Model Decreases Human Breast Cancer Cell Migration. Cureus. 13(12). e20842–e20842. 2 indexed citations
9.
Tarazona, David, et al.. (2020). APRENDIZAJE SOBRE HÁBITOS SALUDABLES EN ESTUDIANTES DE EDUCACIÓN PRIMARIA EN LIMA NORTE. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 7(1). 34–38.
11.
Harris, Daniel, Wei Song, Amol C. Shetty, et al.. (2018). Evolutionary genomic dynamics of Peruvians before, during, and after the Inca Empire. Proceedings of the National Academy of Sciences. 115(28). E6526–E6535. 85 indexed citations
12.
Tarazona, David, et al.. (2018). A rapid identification technique for drug-resistant Mycobacterium tuberculosis isolates using mismatchspecific cleavage enzyme. Bioinformation. 14(7). 404–407. 2 indexed citations
13.
Sotomayor-Beltran, Carlos, et al.. (2018). Anemia During Pregnancy in Peru in 2017: A Geographic Information System Study. 1. 1–5. 1 indexed citations
14.
Tarazona, David, et al.. (2017). A Genomic Signature for Genotyping Mycobacterium tuberculosis. Bioinformation. 13(7). 224–230. 2 indexed citations
15.
Tarazona, David, Marco Galarza, Kelly S. Levano, & Heinner Guio. (2016). Análisis genómico comparativo de cepas peruanas de Mycobacterium tuberculosis. Revista Peruana de Medicina Experimental y Salud Pública. 33(2). 256–256. 5 indexed citations
16.
Guio, Heinner, Kelly S. Levano, César Sánchez, & David Tarazona. (2015). Rol de la farmacogenómica en el régimen de tratamiento de tuberculosis. Revista Peruana de Medicina Experimental y Salud Pública. 32(4). 794–794. 6 indexed citations
17.
Tarazona, David, et al.. (2014). Functional Analysis Using Whole-Genome Sequencing of a Drug-Sensitive Mycobacterium tuberculosis Strain from Peru. Genome Announcements. 2(1). 1 indexed citations
18.
Guio, Heinner, et al.. (2014). Genome Analysis of 17 Extensively Drug-Resistant Strains Reveals New Potential Mutations for Resistance. Genome Announcements. 2(4). 6 indexed citations
19.
Galarza, Marco, et al.. (2014). Evidence of Clonal Expansion in the Genome of a Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolate from Peru. Genome Announcements. 2(1). 4 indexed citations
20.
Cáceres, Omar, Juan D. Montenegro, Carlos Padilla, et al.. (2013). Whole-Genome Sequencing and Comparative Analysis of Yersinia pestis, the Causative Agent of a Plague Outbreak in Northern Peru. Genome Announcements. 1(1). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026